Technet
  • Home
  • About
  • Write
Subscribe   Signin
Blankenship Hickman

Blankenship Hickman

1 post published

Pfizer OPKO : AMM européenne pour NGENLA dans le traitement du déficit en hormone de croissance pédiatrique

Pfizer OPKO : AMM européenne pour NGENLA dans le traitement du déficit en hormone de croissance pédiatrique

amsterdam-online  and practice-related points are needed to guide prescribing physicians while many concerns are still left unresolved (treatment effectiveness or ineffectiveness endpoints, long-term effectiveness, etc.). Approximately 10,000 children in France with growth hormone deficiency (GHD) are being administered daily recombinant human growth hormone (rhGH). — Reevaluation of growth hormone secretion

  • Blankenship Hickman
Blankenship Hickman Feb 5, 2026 • 1 min read
Technet © 2026
  • Data & privacy
  • Contact
  • Contribute →